HtrA2 Polyclonal Antibody

HTRA2 encodes a serine protease. The HtrA serine peptidase 2 has been localized in the endoplasmic reticulum and interacts with an alternatively spliced form of mitogen-activated protein kinase 14. The protein has also been localized to the mitochondria with release to the cytosol following apoptotic stimulus. The protein is thought to induce apoptosis by binding the apoptosis inhibitory protein baculoviral IAP repeat-containing 4. Nuclear localization of this protein has also been observed. Alternate splicing of this gene results in multiple transcript variants encoding different isoforms.

The HtrA2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of HtrA2 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity towards HtrA2.

With its exceptional specificity, this polyclonal antibody enables accurate identification and quantification of HtrA2 in Western blotting, immunohistochemistry, and immunofluorescence applications. It exhibits minimal cross-reactivity with other proteins, ensuring precise and reliable results.

The HtrA2 Polyclonal Antibody is manufactured under stringent quality control measures, guaranteeing batch-to-batch consistency and reproducibility. It is validated for use in multiple species, including human, mouse, and rat, making it a versatile tool for various research applications.

This antibody offers exceptional performance in detecting HtrA2, a serine protease involved in various cellular processes, including apoptosis and protein quality control. Its reliable and accurate results make it an indispensable tool for researchers studying HtrA2-related pathways and diseases.

In summary, the HtrA2 Polyclonal Antibody is a highly specific, sensitive, and reliable tool for the detection and analysis of HtrA2 protein expression. Its exceptional performance and versatility make it an essential component of any research project involving HtrA2-related studies.